Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
基本信息
- 批准号:10473671
- 负责人:
- 金额:$ 22.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-24 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnimalsAntigenic SwitchingAntigenic VariationAreaAttenuatedBlood specimenBorreliaCharacteristicsClinicalComplementDNADNA SequenceDiseaseElementsEventFeverFutureGene ConversionGene ExpressionGeneticGenetic RecombinationGenetic TranscriptionGoalsHeadacheHealthHumanImmune EvasionImmune responseImmunocompetentIndividualInfectionInterruptionInverted Repeat SequencesInvestigationKnowledgeLengthMediatingMembrane ProteinsMessenger RNAMissionMonitorMusMusculoskeletal PainMutationMutation AnalysisNauseaOutcomePathogenesisProcessPromoter RegionsProteinsPublic HealthPublishingQuantitative Reverse Transcriptase PCRRecurrenceRegulationRelapseRelapsing FeverResearchRoleSequence HomologySeriesStructureSymptomsSystemTechniquesTestingTick-Borne Relapsing FeverTimeTranscriptTranslationsUnited StatesUnited States National Institutes of HealthVariantWestern BlottingWorkbasecis acting elementdisabilitygenetic elementgenetic manipulationhuman pathogenmutantpathogenpromoterprotein expressionrelapsing fever borreliatelomeretime intervaltool
项目摘要
Summary
Borrelia hermsii is a causative agent of tick-borne relapsing fever, which is a bacterial illness
characterized by severe recurrent febrile episodes. The undulating fever that is characteristic of the disease is a
direct result of Vmp antigenic variation and sequential immune evasion by the pathogen. Recent work in our lab
has provided evidence that a region upstream from the vmp locus may be involved in the regulation of Vmp
expression, and that a mutant clone deficient in vmp expression was unable to undergo vmp recombination.
Additionally, a mutant clone lacking an inverted DNA repeat residing in a downstream homology region did not
exhibit Vmp antigenic variation. Despite these advancements, the exact identity and role of cis-acting genetic
elements in vmp regulated expression and recombination remain unknown. The objective of our application will
be to identify cis-acting DNA regions of the vmp locus that are important for vmp regulated expression and
recombination. Based on published and preliminary findings, our central hypothesis is that the tandem inverted
repeat sequences are involved in the regulated expression of vmp, and that vmp transcription is required for the
gene conversion process. Additionally, we hypothesize that it is the secondary hairpin structure of the DHS-
resident inverted repeat sequence that is essential for vmp recombination. The rationale for addressing these
knowledge gaps is that the resulting outcomes will lay the groundwork for additional investigations aimed at
disrupting the antigenic variation system that underpins the pathogenesis of disease. Thus, the proposed
research is relevant to that part of NIH’s mission that pertains to developing fundamental knowledge that will
potentially help to reduce the burdens of human illness and disability.
Our central hypothesis will be tested by pursuing three specific aims: 1) Determine the role of the tandem
inverted repeat sequences for regulated expression of vmp, 2) Determine the importance of vmp expression for
gene conversion, and 3) Establish the requirement of the DHS-resident inverted repeat structure for vmp
recombination. Under the first aim, individual inverted DNA repeats will be deleted using our telomere-mediated
deletion/complementation technique. Transcription and translation of vmp from mutant clones or an isogenic wild
type control will be determined via qRT-PCR and Western blot analysis, respectively. Additionally, mRNA
transcript levels will be quantified from blood samples obtained from infected mice at varying time intervals and
compared to those from the wild type control. Under the second aim, mutations will be generated within the vmp
promoter region and used to infect mice to look for a loss of antigenic switching compared to a wild type control.
In the third aim, the inverted repeat within the DHS will be interrupted or DNA sequence altered while retaining
the overall sequence length. Antigenic variation compared to the wild type control will be monitored after infecting
immunocompetent mice. Overall, our experimental approach will allow for direct mutational analysis of putative
cis-acting elements to gain further understanding of this immune evasion system of B. hermsii.
概括
Borrelia hermsii是tick传播发烧的原因,这是细菌疾病
以严重的复发发作发作为特征。疾病特征的起伏热是
VMP抗原变异和病原体的顺序免疫进化的直接结果。我们实验室的最新工作
提供了证据,表明VMP基因座上游的区域可能参与VMP的调节
表达,并且VMP表达中的突变克隆默认值无法进行VMP重组。
此外,缺乏倒在下游同源性区域的倒DNA重复的突变克隆没有
展示VMP抗原变异。尽管取得了这些进步,但顺式作用通用的确切身份和作用
VMP调控表达和重组的元素仍然未知。我们应用的目的将
确定对VMP基因座的顺式作用DNA区域,这些区域对于VMP调节的表达和
重组。基于已发表的初步发现,我们的中心假设是串联倒置
重复序列参与VMP的调节表达,并且VMP转录是需要的
基因转换过程。此外,我们假设它是DHS-的次级发夹结构
居民反向重复序列,这对于VMP重组至关重要。解决这些问题的理由
知识差距是,由此产生的结果将为针对其他投资的基础奠定基础
破坏基于疾病发病机理的抗原变异系统。那,提议
研究与NIH任务的那部分有关,该任务与发展基本知识有关
有可能有助于减少人类疾病和残疾的伯恩斯。
我们的中心假设将通过追求三个具体目标来检验:1)确定串联的作用
倒的重复序列,用于调节VMP的表达,2)确定VMP表达的重要性
基因转化,3)建立了DHS居民倒置重复结构的要求
重组。在第一个目标下,将使用我们的端粒介导的单个倒置DNA重复序列删除
删除/互补技术。来自突变克隆或等生野生的VMP的转录和翻译
类型控制将分别通过QRT-PCR和Western印迹分析确定。另外,mRNA
从感染小鼠以不同的时间间隔和
与野生型控制的那些相比。在第二个目标下,将在VMP中产生突变
与野生型对照相比,启动子区域并用于感染小鼠,以寻找抗原切换的损失。
在第三个目标中,DHS内的反复重复将中断或DNA序列在保留时改变
总序列长度。与野生型控制相比,将在感染后监测抗原变异
免疫能力小鼠。总体而言,我们的实验方法将允许对推定的直接突变分析
顺式作用元素,以进一步了解B. hermsii的这种免疫进化系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Troy Michael Bankhead其他文献
Troy Michael Bankhead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Troy Michael Bankhead', 18)}}的其他基金
Functional and Mechanistic Studies of the VlsE-mediated Immune Avoidance System in the Lyme Disease Spirochete
莱姆病螺旋体 VlsE 介导的免疫回避系统的功能和机制研究
- 批准号:
10371053 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10373101 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Mutational Analysis of Putative Genetic Elements Required for Vmp Regulated Expression and Antigenic Variation by the Relapsing Fever Agent, Borrelia hermsii
回归热病原赫氏疏螺旋体 Vmp 调节表达和抗原变异所需的推定遗传元件的突变分析
- 批准号:
10188845 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Exploratory Studies of lp17-encoded Genetic Factors Important for Tick Colonization by the Lyme Disease Spirochete
对莱姆病螺旋体蜱定殖重要的 lp17 编码遗传因子的探索性研究
- 批准号:
10188065 - 财政年份:2021
- 资助金额:
$ 22.95万 - 项目类别:
Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete
莱姆病螺旋体假定调节因子的机制和功能分析
- 批准号:
10316195 - 财政年份:2020
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8836954 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
8611524 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease Pathogen
莱姆病病原体地方性流行周期中免疫回避的研究
- 批准号:
9247117 - 财政年份:2014
- 资助金额:
$ 22.95万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8501363 - 财政年份:2012
- 资助金额:
$ 22.95万 - 项目类别:
Mutational analysis of the vlp/vsp antigenic variation system of the relapsing fe
复发性FEVLP/VSP抗原变异系统的突变分析
- 批准号:
8354084 - 财政年份:2012
- 资助金额:
$ 22.95万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons
研究 RNA 复制子诱导的 SIV/HIV T 和 B 细胞免疫的保护功效
- 批准号:
10673223 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别:
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
C9orf72额颞叶痴呆的CRISPR基因组编辑器优化及其递送策略
- 批准号:
10746565 - 财政年份:2023
- 资助金额:
$ 22.95万 - 项目类别: